抗菌Indole-3-Carboxamido-Polyamine结合物向细菌膜,并且是抗生素增强剂
Kenneth Sue1, Melissa M Cadelis1,2, Florent Rouvier3
1School of Chemical Sciences, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.
Biomolecules
|March 28, 2024
概括
新的以醇为基础的化合物显示出对抗耐药细菌的抗微生物和抗生素增强作用,没有毒性. 模拟物13b表现出广泛的活性,并增强现有的抗生素,表明膜破坏机制.
科学领域:
- 药用化学 医学化学
- 抗菌研究 抗菌研究
- 药物发现 药物发现 药物发现
背景情况:
- 耐药细菌对全球健康构成重大威胁,需要新的治疗策略.
- 之前对印醇合物的研究显示了抗微生物和抗生素增强活性,但受到细胞毒性限制.
- 需要安全有效的药物来对抗多药耐药性病原体.
研究的目的:
- 为了合成和评估一个新的类别的α,ω-di(英多尔-3-carboxamido) 聚胺衍生物的抗微生物和抗生素增强性质.
- 与以前的化合物相比,识别具有更好的疗效和降低毒性的类似物.
- 研究作用机制,专注于膜破坏.
主要方法:
- 新型α,ω-di ((英多尔-3-碳胺) 聚胺衍生物的合成.
- 对各种细菌和真菌物种的内在抗微生物活性进行生物查.
- 评估与现有抗生素 (多西环素,红素) 结合的抗生素增强效应.
- 对细胞毒性和血解性质的评估.
- 作用机制研究,包括细菌膜完整性测试.
主要成果:
- 几种新型类似物显示出显著的抗微生物和抗生素增强活性.
- 同类型13b对*黄金葡萄球菌*,*青杆菌*和*新型菌* (MIC ≤0.28μM) 具有广泛的活性.
- 同类药物13b增加了21倍的多西环素对*Pseudomonas aeruginosa*的疗效.
- 化合物没有显示出可检测的细胞毒性或溶血性质.
- 类似的13b破坏了细菌膜,这表明了潜在的作用机制.
结论:
- 新合成的α,ω-di,indol-3-carboxamido) 聚胺衍生物是对抗耐药性感染的一类有前途的化合物.
- 模拟物13b是进一步开发的有力候选物,因为它具有广泛的活性,抗生素增强能力和有利的安全性.
- 膜干扰是这些化合物的内在抗微生物作用和抗生素辅助性质的可能机制.
相关概念视频
01:27Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
01:23Antimicrobial Proteins
985
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
985
00:57Antibiotic Selection
53.4K
Overview
53.4K
01:11Aryldiazonium Salts to Azo Dyes: Diazo Coupling
2.9K
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the...
2.9K
01:24Cholinergic Antagonists: Pharmacokinetics
437
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
437
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K